Literature DB >> 25652588

Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44.

Monika Hartmann1, Liseth M Parra2, Anne Ruschel1, Sandra Böhme1, Yong Li1, Helen Morrison1, Andreas Herrlich3, Peter Herrlich4.   

Abstract

UNLABELLED: Ectodomain cleavage (shedding) of transmembrane proteins by metalloproteases (MMP) generates numerous essential signaling molecules, but its regulation is not totally understood. CD44, a cleaved transmembrane glycoprotein, exerts both antiproliferative or tumor-promoting functions, but whether proteolysis is required for this is not certain. CD44-mediated contact inhibition and cellular proliferation are regulated by counteracting CD44 C-terminal interacting proteins, the tumor suppressor protein merlin (NF2) and ERM proteins (ezrin, radixin, moesin). We show here that activation or overexpression of constitutively active merlin or downregulation of ERMs inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced [as well as serum, hepatocyte growth factor (HGF), or platelet-derived growth factor (PDGF)] CD44 cleavage by the metalloprotease ADAM10, whereas overexpressed ERM proteins promoted cleavage. Merlin- and ERM-modulated Ras or Rac activity was not required for this function. However, latrunculin (an actin-disrupting toxin) or an ezrin mutant which is unable to link CD44 to actin, inhibited CD44 cleavage, identifying a cytoskeletal C-terminal link as essential for induced CD44 cleavage. Cellular migration, an important tumor property, depended on CD44 and its cleavage and was inhibited by merlin. These data reveal a novel function of merlin and suggest that CD44 cleavage products play a tumor-promoting role. Neuregulin, an EGF ligand released by ADAM17 from its pro-form NRG1, is predominantly involved in regulating cellular differentiation. In contrast to CD44, release of neuregulin from its pro-form was not regulated by merlin or ERM proteins. Disruption of the actin cytoskeleton however, also inhibited NRG1 cleavage. This current study presents one of the first examples of substrate-selective cleavage regulation. IMPLICATIONS: Investigating transmembrane protein cleavage and their regulatory pathways have provided new molecular insight into their important role in cancer formation and possible treatment. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652588     DOI: 10.1158/1541-7786.MCR-15-0020-T

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  22 in total

1.  Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization.

Authors:  Cornelia Tolg; Muhan Liu; Katelyn Cousteils; Patrick Telmer; Khandakar Alam; Jenny Ma; Leslie Mendina; James B McCarthy; Vincent L Morris; Eva A Turley
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

2.  Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization.

Authors:  Monika Hartmann; Liseth M Parra; Anne Ruschel; Christina Lindner; Helen Morrison; Andreas Herrlich; Peter Herrlich
Journal:  J Biol Chem       Date:  2015-04-29       Impact factor: 5.157

3.  Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.

Authors:  Shilpa Prabhakar; Roberta L Beauchamp; Pike See Cheah; Akiko Yoshinaga; Edwina Abou Haidar; Sevda Lule; Gayathri Mani; Katia Maalouf; Anat Stemmer-Rachamimov; David H Jung; D Bradley Welling; Marco Giovannini; Scott R Plotkin; Casey A Maguire; Vijaya Ramesh; Xandra O Breakefield
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-22       Impact factor: 5.849

Review 4.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

5.  Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.

Authors:  Martin Selmansberger; Herbert Braselmann; Julia Hess; Tetiana Bogdanova; Michael Abend; Mykola Tronko; Alina Brenner; Horst Zitzelsberger; Kristian Unger
Journal:  Carcinogenesis       Date:  2015-08-29       Impact factor: 4.944

6.  Distinct Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain Cleavage of NRG1 or CD44.

Authors:  Liseth M Parra; Monika Hartmann; Salome Schubach; Yong Li; Peter Herrlich; Andreas Herrlich
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

7.  Intranasal administration of vitamin D attenuates blood-brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats.

Authors:  Budbazar Enkhjargal; Devin W McBride; Anatol Manaenko; Cesar Reis; Yasushi Sakai; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 8.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

9.  Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding.

Authors:  Jennifer L Wilson; Eirini Kefaloyianni; Lauren Stopfer; Christina Harrison; Venkata S Sabbisetti; Ernest Fraenkel; Douglas A Lauffenburger; Andreas Herrlich
Journal:  Mol Cancer Res       Date:  2017-10-10       Impact factor: 5.852

10.  P2X7 receptor activity regulation: the role of CD44 proteoglycan GAG chains.

Authors:  G E D D Moura; S V Lucena; M A Lima; F D Nascimento; T F Gesteira; H B Nader; E J Paredes-Gamero; I L S Tersariol
Journal:  Cell Death Dis       Date:  2015-11-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.